Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

This study has been completed.
Information provided by (Responsible Party):
Janssen-Cilag Ltd. Identifier:
First received: February 13, 2012
Last updated: May 20, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)